Sales Have Ended
Join us for our Annual Arrhythmia Symposium at the Renaissance Hotel in Carmel, IN.
8:00 AM - 2:45 PM
7:30-8:00 a.m. - Registration, Continental Breakfast
8:00 a.m. Welcome and Introductions, Eric N. Prystowsky, MD, Program Director
8:00- 9:30a.m. PART I
Panel Members: Scott A. Freeland, PharmD; Jeffrey Hilburn, MD; Girish V. Nair, MD; David Rardon, MD, FACC
Case 1: I can’t take it anymore—I’m going to the Emergency Department!!
Case 2: If I lose weight and I don’t drink coffee, will my AF improve?
Case 3: My Mother had a stroke-can you prevent one in me?
9:30 - 10:00 a.m. BREAK/View Exhibits
10:00 - 10:30 a.m.
B: ECGs: Basics and Blocks
Sandeep Joshi, MD, Girish V. Nair, MD, David Rardon, MD
"Demonsrating the Value of Medicines", Alex M. Azar II, President, Lilly USA, LLC
“The Future of Medical Device Technology”, David M. Steinhaus, Vice President and General Manager, Heart Failure Medical Director, Cardiac Rhythm Heart Failure, Medtronic, Inc.
12:45 – 2:00p.m. PART II
Ventricular Arrhythmias and Syncope
Benzy Padanilam, MD, FACC, Parin Patel, MD, Leonard Steinberg, MD
1. What do you mean I can't participate in competitive sports?
2. Syncope runs in my family
3. Why am I beginning to faint after all these years?
2:00-2:30 p.m. B: ECGs: Tachycardias
Benzy Padanilam, MD, FACC
Leonard Steinberg, MD, FACC
Cardiac arrhythmias may be life-disturbing or life-threatening, and it is key for the health care provider to understand which patients fit into each category. The goal of this year’s Symposium will be a practical approach to patients you may see in your practice and how to approach their problems. The method of teaching will be a case-based approach in which each case presents a specific patient problem that requires both diagnosis and treatment options that will be explored in detail by the faculty with audience interaction.
The program is divided into two parts. The first section will address issues in the care of patients with atrial fibrillation inclucding anticoagulation, rate vs rhythm control strategies, appropriate use of antiarrhythmic drugs, and current approaches to catheter ablation of Afib. There will be discussions of weight loss and sleep apnea and how these can affect AF. A detailed review of prevention of stroke in patients with known and unknown atrial fibrillation will be discussed along with current concepts of cryptogenic stroke.
The second section will allow us to review arrhythmic syndromes in competitive athletes. Case-based learning and extend to other genetic syndromes including long QT, Brugada, hypertrophic cardiomyopathy and ARVC-D. Family history of ventricular tachycardia and ICD implantation and sudden death will be a part of this discussion and the opportunity to discuss syncope and how it relates to risk stratification to prevent sudden death with implantable defibrillators. Management strategies will be discussed for the patient who has a history of vasovagal syncope vasovagal syncope vasovagal syncope.
We look forward to seeing you.